Chronic Pruritus: How to Tailor Management Based on Underlying Cause and Patient Needs
chronic pruritusWow! The ODAC Dermatology Conference in January 2022 highlighted the importance of conference attendance and the need for expert lectures on clinically relevant dermatologic topics.  We are in an era when basic sciences and translational research has direct correlation and impact on our therapeutic measures for patients. While it is refreshing to have so many options for patients’ treatment, it …
chronic pruritus
Successful Treatment of Cheilitis Granulomatosa With Certolizumab and Ustekinumab
Cheilitis Granulomatos INTRODUCTION Cheilitis granulomatosa (CG) is a subtype of orofacial granulomatosis that results in facial and oral swelling in the absence of non-caseating granulomatous systemic diseases such as Crohn’s and sarcoidosis.1 With concurrent facial palsy and a plicated tongue, the condition is referred to as Melkersson-Rosenthal syndrome.1,2 Both CG and Melkersson-Rosenthal syndrome are in the …
Cheilitis Granulomatos
Off-Label Use of Oral Metronidazole in Dermatology | Therapeutic Cheat Sheet
While we have an increasing armamentarium of biologic agents and targeted systemic medications for certain dermatologic conditions such as psoriasis or atopic dermatitis, treatment options are still limited for a litany of other inflammatory cutaneous disorders. Additionally, when discussing therapeutic options, patients often opt for medications that are established, safe, well-tolerated and mini …
An Analysis of Skin of Color Publications in the Journal of Drugs in Dermatology
SOC publicationsINTRODUCTION As the United States population becomes increasingly diverse, it is exceedingly important for dermatologists to be knowledgeable about treating patients with skin of color (SOC). The published literature is an especially valuable resource for treating SOC. Many prevalent dermatological conditions, such as acne vulgaris, atopic dermatitis, and psoriasis, differ histologically and/ …
SOC publications
Pop Quiz #167
The correct answer is D. Acitretin. The image displays palmoplantar pustulosis (PPP) which represents chronic sterile pustules over the palms and soles. Many patients who develop PPP have no pre-existing psoriasis. TNF-a inhibitors have been implicated in the development of palmoplantar pustulosis. Acitretin, among other treatments, is a first line option. This image could also represent …
error

Enjoy this blog? Please spread the word :)